Fig. 1.

Alternative strategies for the treatment of Gaucher disease and other glycosphingolipidoses such as Fabry disease. Most strategies have focused on the restoration of defective missing glycosidase. For type 1 Gaucher disease, enzyme replacement with imiglucerase is the current standard of care. Synthesis inhibition therapy targeting glucosylceramide synthase is an alternative approach.